Search

Displaying results 6831 - 6840 of 9670 in total
  1. Drug

    Labetuzumab

    go.drugbank.com/drugs/DB05097
    Investigational

    It is used in radioimmunotherapy.

  2. Drug

    Lasalocid

    go.drugbank.com/drugs/DB11423
    ExperimentalVet approved

    It is produced by strains of _Streptomyces lasaliensis_.

  3. Drug

    MORAb-066

    go.drugbank.com/drugs/DB17347
    Investigational

    It is being investigated in pancreatic cancer.

  4. Drug

    TCB-008

    go.drugbank.com/drugs/DB18352
    Investigational

    TCB-008 is an Allogeneic CD3+ T lymphocyte ex vivo expanded expressing the gamma delta T-cell receptor.

  5. Drug

    Adipiplon

    go.drugbank.com/drugs/DB06579
    Investigational

    It is known by the standardized identifier NG2-73.

  6. Drug

    Sparsomycin

    go.drugbank.com/drugs/DB04222
    Experimental

    It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]

  7. Drug

    Nordazepam

    go.drugbank.com/drugs/DB14028
    Investigational

    It may have actions similar to those of diazepam.

  8. Drug

    Trotabresib

    go.drugbank.com/drugs/DB17421
    Investigational

    Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.

    Synonyms: Bet inhibitor cc-90010
  9. Drug

    Agerafenib

    go.drugbank.com/drugs/DB15068
    Investigational

    Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations).

  10. Drug

    EC-0652

    go.drugbank.com/drugs/DB15340
    Experimental

    EC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).